Horizon Kinetics Medical ETF (MEDX)

Assets	$16.03M
Expense Ratio	0.85%
PE Ratio	19.02
Shares Out	451,581
Dividend (ttm)	$0.50
Dividend Yield	1.81%
Ex-Dividend Date	Dec 24, 2024
Payout Frequency	Annual
Payout Ratio	34.34%

Volume	339
Open	n/a
Previous Close	27.83
Day's Range	n/a
52-Week Low	23.46
52-Week High	32.00
Beta	0.58
Holdings	35
Inception Date	Jan 27, 2023

About MEDX

Fund Home Page

The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is issued by Horizon.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NASDAQ
• Ticker Symbol: MEDX
• ETF Provider: Horizon

Top 10 Holdings

69.26% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	16.01%
AbbVie Inc.	ABBV	8.93%
Novartis AG ADR	NVSN.MX	7.16%
Amgen Inc.	AMGN	6.11%
US BANK MMDA - USBGFS 7	n/a	6.07%
Alnylam Pharmaceuticals, Inc.	ALNY	5.60%
AstraZeneca PLC	AZN	5.35%
Bristol-Myers Squibb Company	BMY	5.12%
Johnson & Johnson	JNJ	4.78%
Alkermes plc	ALKS	4.15%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 24, 2024	$0.50233	Dec 26, 2024
Dec 27, 2023	$2.88017	Dec 29, 2023

Performance

MEDX had a total return of -6.57% in the past year, including dividends. Since the fund's inception, the average annual return has been -1.81%.